Nov 25 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.
- Danish company Novo Nordisk NOVOb.CO announced on Monday that two large studies failed to find any effect of the drug semaglutide on cognition and functioning in people with mild cognitive impairment, an early stage of Alzheimer's or with dementia.
- The U.S. Consumer Financial Protection Bureau said it would now require its financial examiners to recite a humility pledge to companies before beginning a review.
- U.S. President Donald Trump said he had accepted an invitation from his Chinese counterpart Xi Jinping to visit Beijing in April. That occurred while the two leaders discussed several major issues between their nations, including Taiwan, the war in Ukraine and Chinese purchases of American soybeans.
(Compiled by Bengaluru newsroom)
((globalnewsmonitoring@thomsonreuters.com))
Comments